NEW ERA ” for Interventional Cardiology: Intra Vascular Lithotripsy (IVL) technology to treat coronary calcified blockages.

વિશેષ સમાચાર


The treatment offers high levels of safety and efficacy even in patients having high-risk factors such as diabetes, old age, and poor heart function.


This technology exhibited on Saturday on the sidelines of the National Intervention Council (NIC) of the Cardiological Society of India (CSI) 2022 taking place in Ahmedabad from June 17 to 19.

“The Intravascular Lithotripsy has been a decisive one in changing the treatment outcome of more than 3,500 patients across India since its launch in the country in January 2020. It can be used effectively even in patients having other risk factors like diabetes, old age, and poor heart function or multi vessel disease,” said Dr. Sameer Dani, noted cardiologist from Ahmedabad and Organising Chairman of CSI-NIC 22.

Intravascular Lithotripsy has been used to treat kidney stones for many decades . The same technology has been miniaturised to treat coronary artery calcification.

Calcified lesions often mean percutaneous intervention results are suboptimal and increase the risk of procedural complications and future adverse events. Intravascular Lithotripsy consists of a generator and a catheter which has an array of emitters that emits high-frequency sound waves to the target blockage.

Intravascular Lithotripsy overs many advantages over other technologies, including providing a more controlled means of calcium modification, avoidance of no reflow, continuous simultaneous guidewire position for bifurcation intervention, and the ability to modify calcification without injury to the intimal soft tissue.

The device being approved by the US FDA last year. Successfully helping patients in India to treat this calcium modification

Intravascular Lithotripsy is extremely safe and effective for the treatment of coronary calcium.

How does it work?

* The Intravascular Lithotripsy Catheter is delivered across a calcified lesion over an 0.014” wire and the integrated balloon is expanded to 4atm to facilitate efficient energy transfer.

An electrical discharge from the emitters vaporises the fluid within the balloon, creating a rapidly expanding & collapsing bubble that generates sonic pressure waves.

The waves create a localised field effect that travels through soft vascular tissue, selectively cracking intimal and medial calcium within the vessel wall.

After calcium modification, the integrated balloon may subsequently be used to dilate the lesion at low pressure to maximise luminal gain

Our Media personal also came across one such other technology which is another pathbreaking worlds smallest heart Pump – Called Impella , which is family of medical devices used for temporary ventricular support in patient with depressed heart function.

Dr Sarita Rao , Prominent cardiologist from Indore – Apollo Hospital explained Impella allows the heart to rest and recover by temporary assiting the pumping function of the heart to efficiently deliver blood & oxygen to the entire body during high risk procedure . Moreover patients having Cardigonic shock , which is life threatening condition Impella supports the pumping function of heart providing blood and oxygen to vital organs during treatment.

“Coronary artery calcification is very common in older patients. Coronary intravascular lithotripsy (IVL –Shockwave ) delivers unfocused, circumferential, pulsatile mechanical energy to safely disrupt the calcium within the target lesion. Impella(world’s smallest heart pump ) is also one such device Impella – “ Mechanical circulatory support device ” which protects patient’s from life threatening situations ” said Jigar Patel, Business Development Manager at Translumina . Translumina is known for bringing innovative technology to India from the world.